Immunome, Inc. (IMNM)
18.41
-0.29
(-1.55%)
USD |
NASDAQ |
Nov 13, 11:01
Immunome Net Income (Annual) : -212.39M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -212.39M |
| December 31, 2024 | -292.96M |
| December 31, 2023 | -106.81M |
| December 31, 2022 | -36.90M |
| Date | Value |
|---|---|
| December 31, 2021 | -24.71M |
| December 31, 2020 | -17.84M |
| December 31, 2019 | -10.44M |
| December 31, 2018 | -7.845M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 30.11M |
| Revolution Medicines, Inc. | -1.131B |
| Erasca, Inc. | -124.55M |
| Oncolytics Biotech, Inc. | -28.76M |
| Sangamo Therapeutics, Inc. | -122.93M |